Medicines used for chemotherapy and the treatment of cancer are in increasingly short supply in Iran as the sanctions leveled against it by the international community begin to have collateral effects perhaps unforeseen by those seeking to stop Iran’s march to a nuclear weapon. [New York Times]
Read More